205 related articles for article (PubMed ID: 7667814)
1. Antithrombin III concentrates--are they clinically useful?
Lechner K; Kyrle PA
Thromb Haemost; 1995 Mar; 73(3):340-8. PubMed ID: 7667814
[TBL] [Abstract][Full Text] [Related]
2. [Use of antithrombin III concentrates].
Vinazzer H
Beitr Infusionsther; 1989; 24():151-8. PubMed ID: 2481532
[TBL] [Abstract][Full Text] [Related]
3. Antithrombin III deficiency: clinical relevance and replacement therapy.
Gallus AS
Dev Biol Stand; 1987; 67():59-66. PubMed ID: 3609485
[TBL] [Abstract][Full Text] [Related]
4. Antithrombin III concentrates.
Menache D
Hematol Oncol Clin North Am; 1992 Oct; 6(5):1115-20. PubMed ID: 1400075
[TBL] [Abstract][Full Text] [Related]
5. Treatment with AT III concentrates in hereditary and acquired AT III deficiency.
Gromnica-Ihle E; Ziemer S
Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(3):307-13. PubMed ID: 2465221
[TBL] [Abstract][Full Text] [Related]
6. [Management with antithrombin III concentrate in a pregnant woman with hereditary antithrombin III deficiency].
Higuchi M; Konya H; Tanaka H; Masuda H; Nishida Y; Koyama T; Suehiro A; Kakishita E; Ishita K
Rinsho Ketsueki; 1990 Sep; 31(9):1544-7. PubMed ID: 2246830
[TBL] [Abstract][Full Text] [Related]
7. Management of pregnancy in women with antithrombin III congenital defect: report of four cases.
De Stefano V; Leone G; De Carolis S; Ferrelli R; Di Donfrancesco A; Moneta E; Bizzi B
Thromb Haemost; 1988 Apr; 59(2):193-6. PubMed ID: 3164529
[TBL] [Abstract][Full Text] [Related]
8. Antithrombin supplementation III in childhood acute lymphoblastic leukemia treated with L-asparaginase.
Matsuzaki A; Suminoe A; Hara T
Pediatr Hematol Oncol; 2002 Dec; 19(8):601-3. PubMed ID: 12487838
[TBL] [Abstract][Full Text] [Related]
9. [Prevention of thromboembolism during pregnancy in 3 sisters with congenital antithrombin III deficiency and decreased inducible fibrinolysis].
Schoch U; Zanetti E; von Felten A
Schweiz Med Wochenschr; 1987 Nov; 117(46):1807-10. PubMed ID: 2962279
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of disseminated intravascular coagulation with antithrombin III concentrate in children with verified infection].
Nowak-Göttl U; Groll A; Kreuz WD; Brand M; Breddin HK; von Loewenich V; Kornhuber B
Klin Padiatr; 1992; 204(3):134-40. PubMed ID: 1614177
[TBL] [Abstract][Full Text] [Related]
11. Role of antithrombin concentrate in treatment of hereditary antithrombin deficiency. An update.
Rodgers GM
Thromb Haemost; 2009 May; 101(5):806-12. PubMed ID: 19404531
[TBL] [Abstract][Full Text] [Related]
12. [Familial deficiency of antithrombin III].
Coget JM; Dendien-Bernard S; Dupuis-Cuny C
Phlebologie; 1987; 40(2):381-91. PubMed ID: 3615614
[TBL] [Abstract][Full Text] [Related]
13. Inherited antithrombin deficiency: a review.
Patnaik MM; Moll S
Haemophilia; 2008 Nov; 14(6):1229-39. PubMed ID: 19141163
[TBL] [Abstract][Full Text] [Related]
14. Hereditary antithrombin III deficiency and pregnancy: report of two cases and review of the literature.
Nelson DM; Stempel LE; Brandt JT
Obstet Gynecol; 1985 Jun; 65(6):848-53. PubMed ID: 4039808
[TBL] [Abstract][Full Text] [Related]
15. [Congenital antithrombin III deficiency. Use of concentrates in the prevention of thromboembolic episodes].
Velasco F; Andrés P; Torres A
Med Clin (Barc); 1985 Oct; 85(10):429. PubMed ID: 4079498
[No Abstract] [Full Text] [Related]
16. [Experiences with the substitution of antithrombin III concentrates in congenital and acquired deficiency disorders].
Schramm W
Behring Inst Mitt; 1983 Aug; (73):66-78. PubMed ID: 6332613
[TBL] [Abstract][Full Text] [Related]
17. Familial antithrombin III deficiency.
Winter JH; Fenech A; Ridley W; Bennett B; Cumming AM; Mackie M; Douglas AS
Q J Med; 1982; 51(204):373-95. PubMed ID: 7156320
[TBL] [Abstract][Full Text] [Related]
18. [[Antithrombin III concentrates in the treatmetn of sepsis and septic shock: indictions, limits and future prospects] ].
Baudo F; de Cataldo F
Minerva Anestesiol; 2000 Nov; 66(11 Suppl 1):3-23. PubMed ID: 11213542
[TBL] [Abstract][Full Text] [Related]
19. The prevalence of hereditary antithrombin-III deficiency in patients with a history of venous thromboembolism.
Vikydal R; Korninger C; Kyrle PA; Niessner H; Pabinger I; Thaler E; Lechner K
Thromb Haemost; 1985 Dec; 54(4):744-5. PubMed ID: 4089808
[TBL] [Abstract][Full Text] [Related]
20. [Are there certified indications for the use of antithrombin III in intensive care].
Kulka PJ; Tryba M; Lange S
Anasthesiol Intensivmed Notfallmed Schmerzther; 2001 Mar; 36(3):143-53. PubMed ID: 11324345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
